BOSTON, MA, Day Zero Diagnostics, an infectious disease diagnostics company, announced the recent completion of a $16M round of financing.
Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, announced the recent completion of a $16M round of financing. This latest financing brings the total raised by Day Zero Diagnostics to $49M in venture capital funding and over $18M in non-dilutive funding.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
